Enter assignee name

% Expired Patents = 62.5

EPO Patents = 2

Forward Citations = 59

Loading Chart...

4 inventors (with patents filed for the assignee):

Cohava Gelber (5 out of 10 patents)

James Bender (3 out of 71 patents)

Manish Singh (2 out of 2 patents)

4. John S Yu (1 out of 23 patents)

5. James G Bender (0 patent)

8 patents: Sort by Forward Citations

1. 10137182 - Cancer vaccines and vaccination methods (2018-11-27),

2. 8604167 - CD133 epitopes (2013-12-10),

3. 8383768 - CD133 epitopes (2013-02-26),

4. 7691376 - Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof (2010-04-06),

5. 7687607 - Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS) (2010-03-30),

6. 7498129 - Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof (2009-03-03),

7. 7435554 - Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) (2008-10-14),

8. 7435415 - Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) (2008-10-14),

Immunocellular Therapeutics, Ltd. is a clinical-stage biotechnology company focused on developing and commercializing innovative immunotherapies for the treatment of cancer. The company's lead product candidate, ICT-107, is a personalized dendritic cell-based cancer vaccine that is being evaluated in phase 3 clinical trials for the treatment of glioblastoma multiforme, a type of brain cancer. Immunocellular Therapeutics is dedicated to harnessing the power of the immune system to combat cancer and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.